Morgan L. Locy

1.4k total citations · 1 hit paper
22 papers, 1.1k citations indexed

About

Morgan L. Locy is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Biochemistry. According to data from OpenAlex, Morgan L. Locy has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 12 papers in Molecular Biology and 4 papers in Biochemistry. Recurrent topics in Morgan L. Locy's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Redox biology and oxidative stress (5 papers) and Neonatal Respiratory Health Research (4 papers). Morgan L. Locy is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Redox biology and oxidative stress (5 papers) and Neonatal Respiratory Health Research (4 papers). Morgan L. Locy collaborates with scholars based in United States, United Kingdom and Sweden. Morgan L. Locy's co-authors include Victor J. Thannickal, Sunad Rangarajan, Karen Bernard, Trent E. Tipple, Jaroslaw W. Zmijewski, Jessy S. Deshane, Victor Darley‐Usmar, Saranya Ravi, Lynette K. Rogers and Nathaniel B. Bone and has published in prestigious journals such as Nature Medicine, American Journal of Respiratory and Critical Care Medicine and Scientific Reports.

In The Last Decade

Morgan L. Locy

22 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metformin reverses established lung fibrosis in a bleomycin model

2018 407 citations Sunad Rangarajan, Nathaniel B. Bone et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Morgan L. Locy United States	18	541	428	131	110	105	22	1.1k
Jeffrey D. Ritzenthaler United States	16	449 0.8×	467 1.1×	113 0.9×	108 1.0×	145 1.4×	35	1.2k
Djuro Kosanovic Germany	22	844 1.6×	378 0.9×	198 1.5×	196 1.8×	179 1.7×	62	1.4k
Ajit A. Kulkarni United States	14	457 0.8×	508 1.2×	91 0.7×	70 0.6×	67 0.6×	17	1.1k
Pablo Cannata Spain	11	223 0.4×	373 0.9×	97 0.7×	69 0.6×	93 0.9×	14	879
Laima Tarasevičienė-Stewart United States	10	494 0.9×	281 0.7×	91 0.7×	143 1.3×	221 2.1×	14	913
Rhonda J. Staversky United States	19	437 0.8×	628 1.5×	185 1.4×	70 0.6×	117 1.1×	30	1.1k
Brian Tieu United States	10	286 0.5×	254 0.6×	167 1.3×	56 0.5×	244 2.3×	12	929
Charalambos Michaeloudes United Kingdom	16	406 0.8×	436 1.0×	115 0.9×	420 3.8×	256 2.4×	31	1.2k
Jane F. Arthur Australia	18	223 0.4×	403 0.9×	273 2.1×	86 0.8×	171 1.6×	24	1.5k

Countries citing papers authored by Morgan L. Locy

Since Specialization

Citations

This map shows the geographic impact of Morgan L. Locy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morgan L. Locy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morgan L. Locy more than expected).

Fields of papers citing papers by Morgan L. Locy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morgan L. Locy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morgan L. Locy. The network helps show where Morgan L. Locy may publish in the future.

Co-authorship network of co-authors of Morgan L. Locy

This figure shows the co-authorship network connecting the top 25 collaborators of Morgan L. Locy. A scholar is included among the top collaborators of Morgan L. Locy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morgan L. Locy. Morgan L. Locy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Patton, Michael J., D. Benson, Sarah W. Robison, et al.. (2024). Characteristics and determinants of pulmonary long COVID. JCI Insight. 9(10). 7 indexed citations

Robbins, Mary E., Hye‐Youn Cho, Jason M. Hansen, et al.. (2020). Glutathione reductase deficiency alters lung development and hyperoxic responses in neonatal mice. Redox Biology. 38. 101797–101797. 25 indexed citations

Locy, Morgan L., Sunad Rangarajan, Mark R. Johnson, et al.. (2020). Oxidative cross-linking of fibronectin confers protease resistance and inhibits cellular migration. Science Signaling. 13(644). 17 indexed citations

Qu, Jing, Zijing Zhou, Ping Chen, et al.. (2018). Reversing Mechanoinductive DSP Expression by CRISPR/dCas9–mediated Epigenome Editing. American Journal of Respiratory and Critical Care Medicine. 198(5). 599–609. 35 indexed citations

Li, Qian, et al.. (2018). The thioredoxin reductase inhibitor auranofin induces heme oxygenase-1 in lung epithelial cells via Nrf2-dependent mechanisms. American Journal of Physiology-Lung Cellular and Molecular Physiology. 315(4). L545–L552. 35 indexed citations

Chanda, Diptiman, Eva Otoupalova, Kenneth P. Hough, et al.. (2018). Fibronectin on the Surface of Extracellular Vesicles Mediates Fibroblast Invasion. American Journal of Respiratory Cell and Molecular Biology. 60(3). 279–288. 81 indexed citations

Rangarajan, Sunad, Nathaniel B. Bone, Anna A. Zmijewska, et al.. (2018). Metformin reverses established lung fibrosis in a bleomycin model. Nature Medicine. 24(8). 1121–1127. 407 indexed citations breakdown →

Wall, Stephanie, et al.. (2018). Suppression of site IQ electron leak attenuates lung epithelial cell proliferation. Free Radical Biology and Medicine. 128. S36–S36. 1 indexed citations

O’Reilly, Philip, Qiang Ding, Samia Akthar, et al.. (2017). Angiotensin-converting enzyme defines matrikine-regulated inflammation and fibrosis. JCI Insight. 2(22). 16 indexed citations

10.

Li, Qian, Stephanie Wall, Changchun Ren, et al.. (2016). Thioredoxin Reductase Inhibition Attenuates Neonatal Hyperoxic Lung Injury and Enhances Nuclear Factor E2–Related Factor 2 Activation. American Journal of Respiratory Cell and Molecular Biology. 55(3). 419–428. 46 indexed citations

11.

Rangarajan, Sunad, Morgan L. Locy, Tracy Luckhardt, & Victor J. Thannickal. (2016). Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?. Drugs. 76(3). 291–300. 40 indexed citations

12.

Chanda, Diptiman, Ashish Kurundkar, Sunad Rangarajan, et al.. (2016). Developmental Reprogramming in Mesenchymal Stromal Cells of Human Subjects with Idiopathic Pulmonary Fibrosis. Scientific Reports. 6(1). 37445–37445. 39 indexed citations

13.

Kurundkar, Ashish, Deepali Kurundkar, Sunad Rangarajan, et al.. (2016). The matricellular protein CCN1 enhances TGF‐β1/SMAD3‐dependent profibrotic signaling in fibroblasts and contributes to fibrogenic responses to lung injury. The FASEB Journal. 30(6). 2135–2150. 64 indexed citations

14.

Pennathur, Subramaniam, Anuradha Vivekanandan‐Giri, Morgan L. Locy, et al.. (2015). Oxidative Modifications of Protein Tyrosyl Residues Are Increased in Plasma of Human Subjects with Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine. 193(8). 861–868. 27 indexed citations

15.

Ravi, Saranya, Michelle S. Johnson, Balu K. Chacko, et al.. (2015). Modification of platelet proteins by 4-hydroxynonenal: Potential Mechanisms for inhibition of aggregation and metabolism. Free Radical Biology and Medicine. 91. 143–153. 17 indexed citations

16.

Britt, Rodney D., Markus Velten, Morgan L. Locy, Lynette K. Rogers, & Trent E. Tipple. (2013). The Thioredoxin Reductase-1 Inhibitor Aurothioglucose Attenuates Lung Injury and Improves Survival in a Murine Model of Acute Respiratory Distress Syndrome. Antioxidants and Redox Signaling. 20(17). 2681–2691. 31 indexed citations

17.

Raffay, Thomas M., Morgan L. Locy, Cynthia L. Hill, et al.. (2013). Neonatal Hyperoxic Exposure Persistently Alters Lung Secretoglobins and Annexin A1. BioMed Research International. 2013. 1–10. 13 indexed citations

18.

Chen, Bernadette, et al.. (2013). Thioredoxin-1 mediates hypoxia-induced pulmonary artery smooth muscle cell proliferation. American Journal of Physiology-Lung Cellular and Molecular Physiology. 305(5). L389–L395. 28 indexed citations

19.

Locy, Morgan L., Lynette K. Rogers, Justin R. Prigge, et al.. (2012). Thioredoxin Reductase Inhibition Elicits Nrf2-Mediated Responses in Clara Cells: Implications for Oxidant-Induced Lung Injury. Antioxidants and Redox Signaling. 17(10). 1407–1416. 46 indexed citations

20.

Britt, Rodney D., Morgan L. Locy, Trent E. Tipple, Leif D. Nelin, & Lynette K. Rogers. (2012). Lipopolysaccharide-induced Cyclooxygenase-2 Expression in Mouse Transformed Clara Cells. Cellular Physiology and Biochemistry. 29(1-2). 213–222. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact